Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

beta-Adrenergic blocking agents with acute antihypertensive activity.

J J Baldwin, E L Engelhardt, R Hirschmann

    Journal of Medicinal Chemistry
    |June 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Neurobiology and Neuropharmacology of Alzheimer's Disease. The ASPET - Ray Fuller Symposium. New Orleans, LA, USA, April 19-20, 2002.

    CNS drug reviews·2002
    Same author

    Alzheimer's disease, cancer and the search for a better aspirin. Postgraduate course at Mount Sinai School of Medicine, New York, NY June 22-23, 2001.

    CNS drug reviews·2002
    Same author

    Sixteenth annual meeting of the American Society for Hypertension, San Francisco, CA, USA, May 15-19, 2001.

    Cardiovascular drug reviews·2002
    Same author

    Prediction of drug absorption using multivariate statistics.

    Journal of medicinal chemistry·2000
    Same author

    Allosteric inhibitors of inducible nitric oxide synthase dimerization discovered via combinatorial chemistry.

    Proceedings of the National Academy of Sciences of the United States of America·2000
    Same author

    Glossary of terms used in combinatorial chemistry (technical report).

    Journal of combinatorial chemistry·2000

    Researchers modified a vasodilating/beta-adrenergic blocking agent to create new drugs. New compounds show high cardioselectivity or antihypertensive properties without vasodilating effects, offering potential therapeutic advancements.

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology
    • Cardiovascular Drug Discovery

    Background:

    • The study focuses on modifying compound 1, a known vasodilating and beta-adrenergic blocking agent.
    • Existing beta-adrenergic blocking agents have limitations that necessitate the development of improved therapeutic options.

    Purpose of the Study:

    • To investigate structural modifications of compound 1 to alter its pharmacological profile.
    • To identify novel beta-adrenergic blocking agents with enhanced cardioselectivity or antihypertensive activity.

    Main Methods:

    • Synthesized novel imidazole derivatives by introducing substituents onto the imidazole and aryl rings of compound 1.
    • Evaluated the pharmacological properties of the synthesized compounds, including beta-adrenergic blocking activity, cardioselectivity, and antihypertensive effects.

    Related Experiment Videos

    Main Results:

    • Introduction of substituents on the imidazole ring yielded highly cardioselective beta-adrenergic blocking agents (e.g., 7, 17, 18).
    • Substitution on the aryl ring produced antihypertensive beta-adrenergic blocking agents (e.g., 33).
    • The observed antihypertensive activity was not attributed to vasodilating or beta 2-agonist properties.

    Conclusions:

    • Structural modifications of compound 1 can lead to agents with distinct pharmacological profiles.
    • Novel compounds exhibit promising cardioselective and antihypertensive activities, warranting further investigation for cardiovascular therapies.